Navigation Links
Neurocrine Biosciences Announces Elagolix Scientific Presentations at the 67th Annual Meeting of the American Society for Reproductive Medicine
Date:9/27/2011

SAN DIEGO, Sept. 27, 2011 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that an elagolix podium presentation has been accepted for the scientific program at the 2011 Annual Meeting of the American Society for Reproductive Medicine, to be held October 15-19, 2011 in Orlando, Florida. This annual meeting draws over 4,000 experts from around the world to address current topics related to human reproduction.  

"We are very pleased to participate in the annual meeting of the American Society for Reproductive Medicine," said Chris O'Brien, M.D., Chief Medical Officer at Neurocrine. "Endometriosis is a leading cause of infertility in women and this scientific meeting brings together the world's thought leaders in obstetrics, gynecology, and endocrinology to discuss the latest advances in the field. We look forward to sharing our elagolix clinical data at this meeting."

An abstract from the Daisy Petal clinical study of elagolix for the treatment of endometriosis-associated pain will be presented at the 67th Annual Meeting of the American Society for Reproductive Medicine on Tuesday, October 18, 2011 at 4:15 pm during the abstract sessions. Bruce Carr, M.D. the Paul C. MacDonald Distinguished Chair in Obstetrics and Gynecology at University of Texas Southwestern Medical School will present "A Novel Oral GnRH Antagonist, Elagolix, is Effective For Reducing Endometriosis-Associated Pelvic Pain: Results of a 24-Week Randomized Study."

About Neurocrine Biosciences

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, tardive dyskinesia, uterine fibroids, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders.  Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

In addition to historical facts, this press release may contain forward-looking statements that involve a number of risks and uncertainties. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with Neurocrine's business and finances in general, and Company overall. In addition, the Company faces risks and uncertainties with respect to the Company's R & D pipeline including risk that the Company's clinical candidates will not be found to be safe and effective; and the other risks described in the Company's report on Form 10-K for the year ended December 31, 2010 and report on Form 10-Q for the quarter ended June 30, 2011. Neurocrine undertakes no obligation to update the statements contained in this press release after the date hereof.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
2. Neurocrine Biosciences Announces the Start of Phase II Study of Elagolix in Uterine Fibroids
3. Neurocrine Biosciences To Present at the Stifel Nicolaus 2011 Healthcare Conference
4. Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2011 Financial Results
5. Neurocrine Biosciences Announces elagolix Scientific Presentations at the 11th World Congress on Endometriosis
6. Neurocrine Biosciences to Present at the Jefferies 2011 Global Healthcare Conference
7. Neurocrine Biosciences to Present at the Deutsche Bank 36th Annual Healthcare Conference
8. Neurocrine Biosciences to Present at the 10th Annual Needham Healthcare Conference
9. Neurocrine Biosciences to Present at the Roth 23rd Annual OC Growth Stock Conference
10. Neurocrine Biosciences to Present at Citis 2011 Global Health Care Conference
11. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... , May 3, 2016  Specialty Silicone Fabricators ... that shows how a cleanroom works. The free ... about science and technology. ... a technology company, SSF enthusiastically supports the Science, ... educators foster the next generation of innovators. We ...
(Date:5/2/2016)... 2016 Kalorama Information noted the 5 Most ... in a recent white paper.  The healthcare market research ... a growing market are among the top drivers of ... EMR 2016: The Market for Electronic Medical ... study of the EMR industry, and the report is ...
(Date:5/2/2016)... 2016 The global  ultrasound ... billion by 2024, according to a new report ... of the sonography market include expanding applications of ... for periodic ultrasound screenings of the breast for ... ) High Intensity Focused Ultrasound ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... May 04, 2016 , ... Natalie Jill is a well respected ... preparation of the launch of her new book: Natalie Jill’s 7 Day Jump Start: ... designed to jump start a new healthy lifestyle featuring simple recipes using MitoXcell’s raw ...
(Date:5/4/2016)... ... May 04, 2016 , ... Bayco ... compact tactical (6.7 inch) dual-light flashlights in models NSP-9842XL and NSR-9844XL . ... retail starting at $59.95) uses 2 included CR-123 batteries to produce up to ...
(Date:5/4/2016)... Prairie du Sac, Wisconsin (PRWEB) , ... ... ... The OMNIFORCE collection delivers next-level compression and support for knees, ankles, and ... a great value. , Innovative 3D flat-bed manufacturing (opposed to ineffective circular ...
(Date:5/4/2016)... ... May 04, 2016 , ... Mediware Information Systems, Inc ... application that helps blood and marrow transplant (BMT) programs meet compliance and accreditation ... has continued to enhance core application features. These enhancements are designed to help ...
(Date:5/4/2016)... ... May 04, 2016 , ... Over 40 athletic trainer’s (ATs) and athletic training ... the annual “Hike to Harrisburg” advocacy day. The annual lobbying effort is a ... Group. The goal for the day was to educate the elected legislators and ...
Breaking Medicine News(10 mins):